Through the (funding) desert, on a round with no name

Our recent H1 2023 funding recap highlighted that an astonishing 41% of H1 2023’s funding deals were unlabeled—and this funding trend isn’t likely to go away anytime soon. As startups compete for a share of the high-demand capital needed to scale, we’ve seen digital health headlines reflect a variety of funding approaches—including an unlabeled raise, a Series A extension, and a Series A-3 raise across the past few weeks. Unlabeled rounds are one way for startups to delay “valuation haircuts” and down rounds (raising on a lower valuation than in a prior round) while they work toward proving out clinical outcomes and commercial success. We’re watching to see what other creative funding strategies startups employ as they adjust to the new digital health market reality.


As Digital Health Tech Proliferates, A New Institute Aims To Cut Through Hype
Peterson Health Technology Institute will evaluate health technologies' impact on costs and quality STAT

Digital Health For Aging Populations
Progress, challenges, and opportunities of using technology for geriatric care Nature

Rite Aid Is Testing Out Small Stores To Combat Pharmacy Deserts
Big retailer tries smaller stores to compete with Walgreens and CVS Healthcare Brew

85% Of Employees Don’t Use Their Mental Health Benefits
But two-thirds of survey respondents say they would use a digital mental health benefit if offered MedCity News

Google And Epic Fight Stronger Regulation Of AI In Health Care
Big tech and health companies say “not so fast” to HHS and ONC’s proposed oversight rules STAT

Recent Funding